MAP2K7 and malignant peripheral nerve sheath tumor: A recent study detected several MEK inhibitors (MEKi) to be active in NF1-associated MPNST [6] and the small molecule MEKi and multi kinase inhibitor sorafenib has shown anti-tumor properties in MPNST in vitro [6–8].